There’s hope for those of us who hate exercise.
Japanese scientists are the first to study the natural compound, NMN, in humans to promote healthy aging and increase longevity.
While NMN is already on the market, its effect on humans is unknown.
The Keio University School of Medicine in Tokyo and Washington University School of Medicine in St. Louis are conducting a clinical study of NMN (nicotinamide mononucleoitid), a Niacin derivative.
The goal is to determine the safety and bioavailability of NMN for human use, according to a study in NPJ Aging and Mechanisms of Disease journal.
For 16 years, data has shown significant promise in interactions of Nicotinamide Adenine Dinucleotide (NAD) and sirtuin activity to benefit healthy aging and longevity. NAD is a coenzyme found in all living cells and has several roles in metabolism.
However, NAD is hard to administer to people.
One of its precursors, NMN, is a natural compound that could supplement NAD levels in cells. It’s been proven to reduce complications in glucose metabolism, neural and cardiovascular functions, stem cell maintenance and increased longevity.
Read more about it from Nature.com here.